Quarterly Holdings Report
for
Fidelity® Small Cap Growth Fund
April 30, 2021
Schedule of Investments April 30, 2021 (Unaudited)
Showing Percentage of Net Assets
| Common Stocks - 98.7% | |||
| Shares | Value | ||
| COMMUNICATION SERVICES - 2.1% | |||
| Interactive Media & Services - 0.5% | |||
| JOYY, Inc. ADR | 265,949 | $25,281,112 | |
| Trustpilot Group PLC (a)(b) | 517,888 | 2,238,667 | |
| 27,519,779 | |||
| Media - 1.6% | |||
| Cardlytics, Inc. (a) | 186,488 | 25,647,695 | |
| TechTarget, Inc. (a) | 989,886 | 75,924,256 | |
| 101,571,951 | |||
| TOTAL COMMUNICATION SERVICES | 129,091,730 | ||
| CONSUMER DISCRETIONARY - 18.2% | |||
| Auto Components - 0.3% | |||
| Patrick Industries, Inc. | 214,793 | 19,245,453 | |
| Diversified Consumer Services - 0.7% | |||
| Arco Platform Ltd. Class A (a)(c) | 362,666 | 9,306,010 | |
| Grand Canyon Education, Inc. (a) | 341,852 | 37,019,153 | |
| 46,325,163 | |||
| Hotels, Restaurants & Leisure - 3.4% | |||
| Caesars Entertainment, Inc. (a) | 913,666 | 89,393,081 | |
| Churchill Downs, Inc. | 279,217 | 59,054,396 | |
| Lindblad Expeditions Holdings (a)(d) | 3,898,903 | 63,903,020 | |
| 212,350,497 | |||
| Household Durables - 3.8% | |||
| GoPro, Inc. Class A (a)(c) | 3,109,747 | 34,922,459 | |
| Helen of Troy Ltd. (a)(c) | 92,566 | 19,550,865 | |
| Lovesac (a)(c)(d) | 822,473 | 60,262,597 | |
| M/I Homes, Inc. (a) | 419,545 | 29,250,677 | |
| Purple Innovation, Inc. (a) | 575,290 | 19,605,883 | |
| Sonos, Inc. (a) | 720,592 | 28,845,298 | |
| Taylor Morrison Home Corp. (a) | 761,355 | 23,761,890 | |
| TopBuild Corp. (a)(c) | 89,021 | 19,796,490 | |
| Vuzix Corp. (a) | 107,764 | 2,486,115 | |
| 238,482,274 | |||
| Internet & Direct Marketing Retail - 1.0% | |||
| Farfetch Ltd. Class A (a) | 412,729 | 20,219,594 | |
| Overstock.com, Inc. (a) | 154,373 | 12,581,400 | |
| Porch Group, Inc. Class A (a) | 1,372,700 | 18,270,637 | |
| Revolve Group, Inc. (a) | 289,362 | 14,031,163 | |
| thredUP, Inc. (a)(c) | 65,148 | 1,118,591 | |
| 66,221,385 | |||
| Leisure Products - 0.2% | |||
| YETI Holdings, Inc. (a) | 112,474 | 9,607,529 | |
| Multiline Retail - 0.5% | |||
| Ollie's Bargain Outlet Holdings, Inc. (a) | 312,221 | 28,808,632 | |
| Specialty Retail - 5.0% | |||
| American Eagle Outfitters, Inc. (c) | 2,368,800 | 81,889,416 | |
| Cricut, Inc. (a)(c) | 1,168,782 | 30,972,723 | |
| Dick's Sporting Goods, Inc. (c) | 428,604 | 35,394,118 | |
| Floor & Decor Holdings, Inc. Class A (a) | 391,768 | 43,454,907 | |
| Lithia Motors, Inc. Class A (sub. vtg.) | 129,600 | 49,815,648 | |
| Musti Group OYJ | 404,473 | 15,259,393 | |
| Rent-A-Center, Inc. | 595,726 | 34,284,031 | |
| Williams-Sonoma, Inc. | 163,223 | 27,870,327 | |
| 318,940,563 | |||
| Textiles, Apparel & Luxury Goods - 3.3% | |||
| Crocs, Inc. (a) | 1,205,350 | 120,679,637 | |
| Deckers Outdoor Corp. (a) | 149,670 | 50,618,394 | |
| Tapestry, Inc. | 743,366 | 35,570,063 | |
| 206,868,094 | |||
| TOTAL CONSUMER DISCRETIONARY | 1,146,849,590 | ||
| CONSUMER STAPLES - 2.0% | |||
| Beverages - 0.0% | |||
| Duckhorn Portfolio, Inc. (a) | 51,894 | 970,937 | |
| Food & Staples Retailing - 1.0% | |||
| BJ's Wholesale Club Holdings, Inc. (a) | 1,449,681 | 64,757,250 | |
| Food Products - 0.7% | |||
| Darling Ingredients, Inc. (a) | 325,443 | 22,602,016 | |
| Nomad Foods Ltd. (a) | 710,557 | 20,719,842 | |
| 43,321,858 | |||
| Personal Products - 0.3% | |||
| Herbalife Nutrition Ltd. (a) | 338,504 | 15,493,328 | |
| TOTAL CONSUMER STAPLES | 124,543,373 | ||
| ENERGY - 0.6% | |||
| Oil, Gas & Consumable Fuels - 0.6% | |||
| Enviva Partners LP | 312,232 | 15,377,426 | |
| Renewable Energy Group, Inc. (a)(c) | 404,628 | 22,464,947 | |
| 37,842,373 | |||
| FINANCIALS - 6.8% | |||
| Banks - 1.4% | |||
| Associated Banc-Corp. | 812,764 | 17,791,404 | |
| Glacier Bancorp, Inc. | 294,447 | 17,357,651 | |
| Hilltop Holdings, Inc. | 485,633 | 17,094,282 | |
| PacWest Bancorp | 314,579 | 13,655,874 | |
| Signature Bank | 69,927 | 17,587,340 | |
| Silvergate Capital Corp. (a) | 47,999 | 5,146,453 | |
| 88,633,004 | |||
| Capital Markets - 3.1% | |||
| Cowen Group, Inc. Class A (c) | 669,521 | 26,439,384 | |
| Hamilton Lane, Inc. Class A | 103,636 | 9,373,876 | |
| Impax Asset Management Group PLC | 96,726 | 1,341,178 | |
| Lazard Ltd. Class A | 304,434 | 13,696,486 | |
| LPL Financial | 314,238 | 49,241,095 | |
| Morningstar, Inc. | 105,903 | 28,065,354 | |
| StepStone Group, Inc. Class A | 1,516,821 | 50,510,139 | |
| Vesper Healthcare Acquisition Corp. Class A (a) | 1,579,800 | 18,278,286 | |
| 196,945,798 | |||
| Consumer Finance - 0.3% | |||
| Green Dot Corp. Class A (a) | 91,425 | 4,183,608 | |
| OneMain Holdings, Inc. | 301,495 | 17,146,021 | |
| 21,329,629 | |||
| Diversified Financial Services - 0.6% | |||
| Mudrick Capital Acquisition Corp. II Class A (a) | 1,021,003 | 16,468,778 | |
| Northern Star Acquisition Corp. unit (d) | 1,742,114 | 19,877,521 | |
| 36,346,299 | |||
| Insurance - 1.4% | |||
| American Financial Group, Inc. | 345,471 | 42,444,567 | |
| Assurant, Inc. | 184,488 | 28,706,333 | |
| BRP Group, Inc. (a) | 601,144 | 17,445,199 | |
| 88,596,099 | |||
| TOTAL FINANCIALS | 431,850,829 | ||
| HEALTH CARE - 29.8% | |||
| Biotechnology - 13.4% | |||
| 4D Molecular Therapeutics, Inc. (c) | 307,601 | 11,904,159 | |
| Acceleron Pharma, Inc. (a) | 128,866 | 16,104,384 | |
| ADC Therapeutics SA (a) | 215,014 | 5,276,444 | |
| Agios Pharmaceuticals, Inc. (a) | 357,013 | 19,921,325 | |
| Allovir, Inc. (a)(c) | 451,175 | 10,661,265 | |
| ALX Oncology Holdings, Inc. (a)(c) | 277,147 | 17,366,031 | |
| Annexon, Inc. (a) | 258,577 | 5,153,440 | |
| Arcutis Biotherapeutics, Inc. (a) | 13,500 | 452,250 | |
| Argenx SE ADR (a) | 109,004 | 31,252,537 | |
| Ascendis Pharma A/S sponsored ADR (a) | 229,102 | 33,212,917 | |
| Avid Bioservices, Inc. (a) | 926,634 | 19,834,601 | |
| Blueprint Medicines Corp. (a) | 363,957 | 35,056,338 | |
| Bolt Biotherapeutics, Inc. | 518,589 | 11,595,650 | |
| Cytokinetics, Inc. (a) | 341,498 | 8,687,709 | |
| Edgewise Therapeutics, Inc. (a) | 460,639 | 13,192,701 | |
| Exelixis, Inc. (a) | 1,221,278 | 30,067,864 | |
| Forma Therapeutics Holdings, Inc. | 447,674 | 12,064,814 | |
| Halozyme Therapeutics, Inc. (a) | 764,213 | 38,172,439 | |
| Immunocore Holdings PLC ADR | 323,622 | 13,061,384 | |
| ImmunoGen, Inc. (a) | 1,299,849 | 10,476,783 | |
| Instil Bio, Inc. (a) | 154,700 | 3,175,991 | |
| Instil Bio, Inc. | 1,253,977 | 23,169,733 | |
| Iovance Biotherapeutics, Inc. (a) | 273,005 | 8,583,277 | |
| Keros Therapeutics, Inc. | 269,353 | 15,837,956 | |
| Kura Oncology, Inc. (a) | 981,130 | 26,421,831 | |
| Kymera Therapeutics, Inc. (a) | 293,353 | 13,362,229 | |
| Mirati Therapeutics, Inc. (a) | 93,561 | 15,551,709 | |
| Morphic Holding, Inc. (a) | 371,803 | 20,597,886 | |
| Natera, Inc. (a) | 392,730 | 43,208,155 | |
| Neurocrine Biosciences, Inc. (a) | 132,831 | 12,551,201 | |
| Novavax, Inc. (a) | 98,731 | 23,392,336 | |
| ORIC Pharmaceuticals, Inc. (a) | 49,158 | 1,186,183 | |
| Passage Bio, Inc. (a) | 715,171 | 13,416,608 | |
| Prelude Therapeutics, Inc. | 419,870 | 17,399,413 | |
| ProQR Therapeutics BV (a)(c)(d) | 3,556,098 | 22,118,930 | |
| Protagonist Therapeutics, Inc. (a) | 747,093 | 21,620,871 | |
| PTC Therapeutics, Inc. (a) | 415,500 | 17,122,755 | |
| Relay Therapeutics, Inc. (a) | 534,777 | 16,957,779 | |
| Repare Therapeutics, Inc. | 446,700 | 14,607,090 | |
| Repligen Corp. (a) | 73,357 | 15,530,410 | |
| Revolution Medicines, Inc. (a) | 673,041 | 22,338,231 | |
| Shattuck Labs, Inc. | 90,200 | 3,398,736 | |
| Silverback Therapeutics, Inc. | 79,070 | 2,534,194 | |
| Stoke Therapeutics, Inc. (a) | 3,600 | 116,280 | |
| Taysha Gene Therapies, Inc. | 99,617 | 2,571,115 | |
| TG Therapeutics, Inc. (a) | 1,295,995 | 57,943,936 | |
| Turning Point Therapeutics, Inc. (a) | 79,416 | 6,053,882 | |
| United Therapeutics Corp. (a) | 128,207 | 25,841,403 | |
| Veracyte, Inc. (a)(c) | 172,075 | 8,560,731 | |
| Vericel Corp. (a) | 345,400 | 21,559,868 | |
| Xenon Pharmaceuticals, Inc. (a) | 224,674 | 4,116,028 | |
| 844,361,782 | |||
| Health Care Equipment & Supplies - 5.6% | |||
| Axonics Modulation Technologies, Inc. (a) | 522,997 | 32,912,201 | |
| CryoPort, Inc. (a)(c) | 265,040 | 14,993,313 | |
| Envista Holdings Corp. (a) | 729,400 | 31,568,432 | |
| Globus Medical, Inc. (a) | 253,900 | 18,222,403 | |
| Insulet Corp. (a) | 283,584 | 83,719,668 | |
| Integer Holdings Corp. (a) | 391,453 | 36,749,608 | |
| Neuronetics, Inc. (a) | 719,699 | 7,556,840 | |
| Nevro Corp. (a) | 303,000 | 52,361,430 | |
| OrthoPediatrics Corp. (a)(c) | 191,377 | 11,195,555 | |
| PAVmed, Inc. (a)(c) | 1,185,407 | 5,417,310 | |
| Pulmonx Corp. (c) | 202,490 | 9,519,055 | |
| Tandem Diabetes Care, Inc. (a) | 194,266 | 17,853,045 | |
| TransMedics Group, Inc. (a) | 562,272 | 16,142,829 | |
| ViewRay, Inc. (a) | 3,326,407 | 16,000,018 | |
| 354,211,707 | |||
| Health Care Providers & Services - 5.1% | |||
| Acadia Healthcare Co., Inc. (a) | 358,296 | 21,827,392 | |
| Accolade, Inc. (a) | 115,920 | 5,813,388 | |
| Castle Biosciences, Inc. (a)(c) | 153,252 | 10,578,986 | |
| Chemed Corp. | 30,689 | 14,626,684 | |
| Ikena Oncology, Inc. (a) | 192,799 | 4,717,792 | |
| Ikena Oncology, Inc. | 509,561 | 11,222,062 | |
| Molina Healthcare, Inc. (a) | 192,023 | 48,985,067 | |
| Option Care Health, Inc. (a) | 1,421,371 | 27,119,759 | |
| PetIQ, Inc. Class A (a)(c) | 258,577 | 11,015,380 | |
| Progyny, Inc. (a) | 767,727 | 43,691,344 | |
| R1 RCM, Inc. (a) | 1,440,849 | 39,306,361 | |
| Signify Health, Inc. | 500,599 | 14,191,982 | |
| Surgery Partners, Inc. (a) | 141,893 | 6,839,243 | |
| The Ensign Group, Inc. | 462,778 | 39,729,491 | |
| The Joint Corp. (a) | 404,379 | 22,434,947 | |
| 322,099,878 | |||
| Health Care Technology - 2.2% | |||
| Certara, Inc. (c) | 428,143 | 13,619,229 | |
| Health Catalyst, Inc. (a) | 450,203 | 26,066,754 | |
| Inspire Medical Systems, Inc. (a) | 204,363 | 48,397,246 | |
| Phreesia, Inc. (a) | 645,883 | 33,424,445 | |
| Schrodinger, Inc. (a)(c) | 223,573 | 17,045,206 | |
| 138,552,880 | |||
| Life Sciences Tools & Services - 3.1% | |||
| 10X Genomics, Inc. (a) | 160,992 | 31,844,218 | |
| Berkeley Lights, Inc. (a) | 250,762 | 12,314,922 | |
| Bruker Corp. | 351,283 | 24,069,911 | |
| Charles River Laboratories International, Inc. (a) | 91,730 | 30,495,639 | |
| Medpace Holdings, Inc. (a) | 91,446 | 15,516,557 | |
| Nanostring Technologies, Inc. (a) | 339,647 | 27,059,676 | |
| Olink Holding AB ADR (a) | 318,596 | 11,214,579 | |
| Syneos Health, Inc. (a) | 504,151 | 42,777,212 | |
| 195,292,714 | |||
| Pharmaceuticals - 0.4% | |||
| Aclaris Therapeutics, Inc. (a) | 92,907 | 2,215,832 | |
| IMARA, Inc. (a) | 270,214 | 1,999,584 | |
| Pharvaris BV (c) | 523,175 | 12,608,518 | |
| SCYNEXIS, Inc. warrants 6/21/21 (a) | 16,875 | 0 | |
| Theravance Biopharma, Inc. (a) | 424,987 | 8,389,243 | |
| 25,213,177 | |||
| TOTAL HEALTH CARE | 1,879,732,138 | ||
| INDUSTRIALS - 15.7% | |||
| Aerospace & Defense - 1.0% | |||
| Axon Enterprise, Inc. (a) | 140,672 | 21,327,282 | |
| BWX Technologies, Inc. | 658,350 | 44,056,782 | |
| 65,384,064 | |||
| Air Freight & Logistics - 0.1% | |||
| Air Transport Services Group, Inc. (a) | 292,224 | 7,691,336 | |
| Building Products - 4.4% | |||
| Builders FirstSource, Inc. (a) | 2,274,908 | 110,719,772 | |
| Fortune Brands Home & Security, Inc. | 312,321 | 32,787,459 | |
| Resideo Technologies, Inc. (a) | 734,786 | 22,050,928 | |
| Simpson Manufacturing Co. Ltd. | 219,427 | 24,729,423 | |
| The AZEK Co., Inc. | 1,129,592 | 54,536,702 | |
| UFP Industries, Inc. | 353,310 | 29,692,172 | |
| 274,516,456 | |||
| Commercial Services & Supplies - 1.1% | |||
| Montrose Environmental Group, Inc. (a) | 583,744 | 31,644,762 | |
| The Brink's Co. | 476,488 | 38,080,921 | |
| 69,725,683 | |||
| Construction & Engineering - 0.5% | |||
| MasTec, Inc. (a) | 319,800 | 33,374,328 | |
| Electrical Equipment - 2.0% | |||
| Array Technologies, Inc. | 1,135,718 | 31,981,819 | |
| Regal Beloit Corp. | 176,661 | 25,515,148 | |
| Sensata Technologies, Inc. PLC (a) | 701,264 | 40,490,983 | |
| Shoals Technologies Group, Inc. | 380,963 | 12,217,483 | |
| Sunrun, Inc. (a) | 337,160 | 16,520,840 | |
| 126,726,273 | |||
| Machinery - 2.4% | |||
| Chart Industries, Inc. (a) | 117,161 | 18,819,571 | |
| Crane Co. | 399,718 | 37,597,475 | |
| ESCO Technologies, Inc. | 213,814 | 23,254,411 | |
| ITT, Inc. | 460,285 | 43,409,478 | |
| Kornit Digital Ltd. (a) | 178,422 | 17,442,535 | |
| SPX Corp. (a) | 207,782 | 12,604,056 | |
| 153,127,526 | |||
| Professional Services - 3.3% | |||
| ASGN, Inc. (a) | 386,472 | 40,649,125 | |
| CACI International, Inc. Class A (a) | 158,521 | 40,400,662 | |
| Clarivate Analytics PLC (a)(c) | 586,786 | 16,388,933 | |
| KBR, Inc. | 1,792,405 | 70,907,542 | |
| TriNet Group, Inc. (a) | 155,850 | 12,266,954 | |
| Upwork, Inc. (a) | 573,012 | 26,392,933 | |
| 207,006,149 | |||
| Trading Companies & Distributors - 0.9% | |||
| Applied Industrial Technologies, Inc. | 237,269 | 22,697,153 | |
| Beacon Roofing Supply, Inc. (a) | 374,611 | 21,101,838 | |
| Custom Truck One Source, Inc. Class A (a)(c) | 1,219,753 | 12,514,666 | |
| 56,313,657 | |||
| TOTAL INDUSTRIALS | 993,865,472 | ||
| INFORMATION TECHNOLOGY - 17.9% | |||
| Communications Equipment - 0.3% | |||
| Lumentum Holdings, Inc. (a) | 250,301 | 21,288,100 | |
| Electronic Equipment & Components - 0.8% | |||
| Fabrinet (a) | 456,809 | 39,111,987 | |
| SYNNEX Corp. | 87,117 | 10,558,580 | |
| 49,670,567 | |||
| IT Services - 1.1% | |||
| Genpact Ltd. | 908,900 | 43,200,017 | |
| Nuvei Corp. (a)(b) | 304,811 | 21,269,712 | |
| Perficient, Inc. (a) | 16,178 | 1,061,439 | |
| 65,531,168 | |||
| Semiconductors & Semiconductor Equipment - 4.7% | |||
| Advanced Energy Industries, Inc. | 573,444 | 63,256,608 | |
| Ambarella, Inc. (a) | 167,266 | 16,306,762 | |
| Brooks Automation, Inc. | 172,468 | 17,476,182 | |
| Cirrus Logic, Inc. (a) | 330,615 | 24,601,062 | |
| CMC Materials, Inc. | 239,151 | 43,867,468 | |
| eMemory Technology, Inc. | 363,000 | 13,379,495 | |
| Nova Measuring Instruments Ltd. (a) | 161,949 | 15,283,127 | |
| Semtech Corp. (a) | 550,468 | 37,288,702 | |
| SiTime Corp. (a) | 708,661 | 65,586,576 | |
| 297,045,982 | |||
| Software - 10.2% | |||
| Alkami Technology, Inc. (a) | 3,100 | 147,839 | |
| Alkami Technology, Inc. | 893,236 | 38,338,582 | |
| Anaplan, Inc. (a) | 163,732 | 9,766,614 | |
| ChannelAdvisor Corp. (a) | 654,702 | 13,846,947 | |
| CyberArk Software Ltd. (a) | 227,980 | 32,031,190 | |
| Digital Turbine, Inc. (a) | 666,817 | 50,298,006 | |
| DoubleVerify Holdings, Inc. (a) | 411,735 | 14,497,189 | |
| DoubleVerify Holdings, Inc. | 291,700 | 9,243,681 | |
| Dynatrace, Inc. (a) | 941,626 | 49,002,217 | |
| Elastic NV (a) | 279,767 | 33,745,496 | |
| FireEye, Inc. (a) | 1,687,203 | 33,533,160 | |
| Lightspeed POS, Inc. (Canada) (a) | 301,726 | 21,069,147 | |
| LivePerson, Inc. (a) | 602,595 | 32,931,817 | |
| Nuance Communications, Inc. (a) | 515,760 | 27,422,959 | |
| Rapid7, Inc. (a) | 583,959 | 47,446,669 | |
| Smith Micro Software, Inc. (a) | 134,322 | 754,890 | |
| Sprout Social, Inc. (a) | 1,034,774 | 68,595,168 | |
| TECSYS, Inc. | 526,763 | 19,336,571 | |
| Telos Corp. | 793,756 | 26,336,824 | |
| Tenable Holdings, Inc. (a) | 1,179,679 | 44,232,064 | |
| Upsales Technology AB (a) | 514,571 | 5,470,571 | |
| Workiva, Inc. (a) | 288,522 | 27,121,068 | |
| Xperi Holding Corp. | 725,282 | 14,904,545 | |
| Yext, Inc. (a) | 1,673,773 | 23,349,133 | |
| 643,422,347 | |||
| Technology Hardware, Storage & Peripherals - 0.8% | |||
| Seagate Technology LLC | 540,609 | 50,190,140 | |
| TOTAL INFORMATION TECHNOLOGY | 1,127,148,304 | ||
| MATERIALS - 2.9% | |||
| Chemicals - 1.5% | |||
| Element Solutions, Inc. | 1,430,364 | 31,296,364 | |
| The Chemours Co. LLC | 833,072 | 25,158,774 | |
| Valvoline, Inc. | 1,149,315 | 36,088,491 | |
| 92,543,629 | |||
| Construction Materials - 0.5% | |||
| Eagle Materials, Inc. | 224,259 | 30,979,138 | |
| Containers & Packaging - 0.4% | |||
| Avery Dennison Corp. | 127,734 | 27,356,791 | |
| Metals & Mining - 0.5% | |||
| Iluka Resources Ltd. | 1,300,614 | 7,754,923 | |
| Lynas Rare Earths Ltd. (a) | 1,455,964 | 6,168,810 | |
| Reliance Steel & Aluminum Co. | 119,028 | 19,081,379 | |
| 33,005,112 | |||
| TOTAL MATERIALS | 183,884,670 | ||
| REAL ESTATE - 1.6% | |||
| Equity Real Estate Investment Trusts (REITs) - 0.5% | |||
| Potlatch Corp. | 124,852 | 7,411,215 | |
| Rexford Industrial Realty, Inc. | 230,600 | 12,809,830 | |
| Terreno Realty Corp. | 177,005 | 11,420,363 | |
| 31,641,408 | |||
| Real Estate Management & Development - 1.1% | |||
| Compass, Inc. | 3,623,914 | 62,034,160 | |
| Jones Lang LaSalle, Inc. (a) | 52,718 | 9,906,239 | |
| 71,940,399 | |||
| TOTAL REAL ESTATE | 103,581,807 | ||
| UTILITIES - 1.1% | |||
| Independent Power and Renewable Electricity Producers - 1.1% | |||
| Clearway Energy, Inc. Class C | 345,677 | 9,917,473 | |
| FTC Solar, Inc. (a) | 1,065,609 | 14,502,938 | |
| NextEra Energy Partners LP | 178,800 | 13,329,540 | |
| Sunnova Energy International, Inc. (a) | 933,009 | 32,953,878 | |
| 70,703,829 | |||
| TOTAL COMMON STOCKS | |||
| (Cost $4,598,954,440) | 6,229,094,115 | ||
| Convertible Preferred Stocks - 1.8% | |||
| CONSUMER DISCRETIONARY - 0.5% | |||
| Specialty Retail - 0.4% | |||
| Fanatics, Inc.: | |||
| Series E (e)(f) | 707,802 | 24,681,056 | |
| Series F (e)(f) | 18,260 | 636,726 | |
| 25,317,782 | |||
| Textiles, Apparel & Luxury Goods - 0.1% | |||
| Nuvalent, Inc. Series B (e)(f) | 2,951,928 | 6,109,901 | |
| TOTAL CONSUMER DISCRETIONARY | 31,427,683 | ||
| HEALTH CARE - 0.1% | |||
| Health Care Providers & Services - 0.1% | |||
| Boundless Bio, Inc. Series B (e)(f) | 3,017,761 | 4,073,977 | |
| INDUSTRIALS - 0.5% | |||
| Construction & Engineering - 0.3% | |||
| Beta Technologies, Inc. Series A (e)(f) | 278,129 | 20,378,512 | |
| Road & Rail - 0.2% | |||
| Convoy, Inc. Series D (a)(e)(f) | 913,444 | 13,007,443 | |
| TOTAL INDUSTRIALS | 33,385,955 | ||
| INFORMATION TECHNOLOGY - 0.7% | |||
| Communications Equipment - 0.2% | |||
| Astranis Space Technologies Corp. Series C (e)(f) | 557,717 | 12,225,675 | |
| IT Services - 0.5% | |||
| Yanka Industries, Inc.: | |||
| Series E (e)(f) | 869,641 | 27,721,372 | |
| Series F (e)(f) | 127,716 | 4,071,177 | |
| 31,792,549 | |||
| TOTAL INFORMATION TECHNOLOGY | 44,018,224 | ||
| TOTAL CONVERTIBLE PREFERRED STOCKS | |||
| (Cost $82,606,465) | 112,905,839 | ||
| Principal Amount | Value | ||
| Convertible Bonds - 0.0% | |||
| CONSUMER DISCRETIONARY - 0.0% | |||
| Textiles, Apparel & Luxury Goods - 0.0% | |||
| AbSci Corp. 6% (f)(g) | |||
| (Cost $1,870,000) | 1,870,000 | 1,870,000 | |
| Shares | Value | ||
| Money Market Funds - 4.7% | |||
| Fidelity Cash Central Fund 0.04% (h) | 39,957,409 | 39,965,401 | |
| Fidelity Securities Lending Cash Central Fund 0.04% (h)(i) | 259,009,222 | 259,035,123 | |
| TOTAL MONEY MARKET FUNDS | |||
| (Cost $299,000,524) | 299,000,524 | ||
| TOTAL INVESTMENT IN SECURITIES - 105.2% | |||
| (Cost $4,982,431,429) | 6,642,870,478 | ||
| NET OTHER ASSETS (LIABILITIES) - (5.2)% | (329,336,815) | ||
| NET ASSETS - 100% | $6,313,533,663 |
Legend
(a) Non-income producing
(b) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $23,508,379 or 0.4% of net assets.
(c) Security or a portion of the security is on loan at period end.
(d) Affiliated company
(e) Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $112,905,839 or 1.8% of net assets.
(f) Level 3 security
(g) Security is perpetual in nature with no stated maturity date.
(h) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
(i) Investment made with cash collateral received from securities on loan.
Additional information on each restricted holding is as follows:
| Security | Acquisition Date | Acquisition Cost |
| Astranis Space Technologies Corp. Series C | 3/19/21 | $12,225,675 |
| Beta Technologies, Inc. Series A | 4/9/21 | $20,378,512 |
| Boundless Bio, Inc. Series B | 4/23/21 | $4,073,977 |
| Convoy, Inc. Series D | 10/30/19 | $12,368,032 |
| Fanatics, Inc. Series E | 8/13/20 | $12,237,897 |
| Fanatics, Inc. Series F | 3/22/21 | $636,726 |
| Nuvalent, Inc. Series B | 4/30/21 | $6,109,901 |
| Yanka Industries, Inc. Series E | 5/15/20 | $10,504,568 |
| Yanka Industries, Inc. Series F | 4/8/21 | $4,071,177 |
Affiliated Central Funds
Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:
| Fund | Income earned |
| Fidelity Cash Central Fund | $15,768 |
| Fidelity Securities Lending Cash Central Fund | 505,649 |
| Total | $521,417 |
Amounts in the income column in the above table include any capital gain distributions from underlying funds. Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
Other Affiliated Issuers
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities. Fiscal year to date transactions with companies which are or were affiliates are as follows:
| Affiliate | Value, beginning of period | Purchases | Sales Proceeds | Dividend Income | Realized Gain (loss) | Change in Unrealized appreciation (depreciation) | Value, end of period |
| Lindblad Expeditions Holdings | $4,132,761 | $47,787,052 | $6,757,234 | $-- | $958,286 | $17,782,155 | $63,903,020 |
| Lovesac | -- | 50,844,188 | -- | -- | -- | 9,418,409 | 60,262,597 |
| Northern Star Acquisition Corp. unit | -- | 30,849,630 | 9,867,542 | -- | 1,083,106 | (2,187,673) | 19,877,521 |
| ProQR Therapeutics BV | -- | 24,125,354 | -- | -- | -- | (2,006,424) | 22,118,930 |
| SiTime Corp. | 46,580,660 | 17,402,572 | 34,391,591 | -- | 17,563,574 | 18,431,361 | -- |
| Total | $50,713,421 | $171,008,796 | $51,016,367 | $-- | $19,604,966 | $41,437,828 | $166,162,068 |
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy. Securities, including private placements or other restricted securities, for which observable inputs are not available are valued using alternate valuation approaches, including the market approach, the income approach and cost approach are categorized as Level 3 in the hierarchy. The market approach considers factors including the price of recent investments in the same or a similar security or financial metrics of comparable securities. The income approach considers factors including expected future cash flows, security specific risks and corresponding discount rates. The cost approach considers factors including the value of the security’s underlying assets and liabilities.
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. Corporate bonds are valued by pricing vendors who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker supplied prices.
When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.